Logo

LevitasBio: Paul Steinberg and Joseph Walthers

Jan 14, 2021

LevitasBio, a Stanford University spinout, has appointed Paul Steinberg as chief commercial officer and Joseph Walthers as VP of finance.

Steinberg will lead LevitasBio's commercial roadmap and strategy and manage commercial functions at the firm. He was most recently VP of worldwide sales at NanoString Technologies and has held leadership roles in commercialization and business development at Fluidigm and Thermo Fisher Scientific, respectively. He holds a master's degree in analytical chemistry from the University of Miami.

Walthers will be responsible for financial planning, budgeting, accounting, risk management, and internal controls activities. He has over 20 years experience at life science and biotech companies including Twist Bioscience, Natera, and Rainin Instrument. He is a licensed CPA in California.

Breaking News
The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.